Tuesday, January 28, 2020

January 28, 2020 at 01:03PM Testing of Retroviral Vector-Based Human Gene Therapy Products for Replication Competent Retrovirus During Product Manufacture and Patient Follow-up

Testing of Retroviral Vector-Based Human Gene Therapy Products for Replication Competent Retrovirus During Product Manufacture and Patient Follow-up, Guidance, CBER, Biologics

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/312vrPy

No comments:

Post a Comment